Investment analysts at William Blair issued their Q1 2026 earnings estimates for MaxCyte in a report released on Wednesday, March 12th. William Blair analyst M. Larew expects that the company will ...

MaxCyte (NASDAQ:MXCT – Free Report) had its price objective cut by Stifel Nicolaus from $11.00 to $9.00 in a report released on Wednesday morning,Benzinga reports. They currently have a buy rating on ...

MaxCyte, Inc. is rated a "Buy" due to significant upside potential despite recent share price declines. The company's core revenue is increasing and growth strategies have good prospects, driven ...

Fourth Quarter and Full Year Highlights Total revenue of $8.7 million in the fourth quarter of 2024, TG Therapeutics to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to ...

Get inspired to transform your live-cell assays Accurately counting viable cells in a sample is crucial for various biological assays, including normalization and assessing drug impacts ... Health & ...

Seagate Technology Holdings plc engages in the provision of data storage technology and infrastructure solutions in Singapore, the United States, the Netherlands, and internationally. The company ...

What is the current share price of Strike Energy Limited (STX)? Strike Energy Limited's (STX) current share price is $0.18. This constitutes a price movement of 2.94% when compared to the share price ...

After hours: March 14 at 7:09:16 PM EDT Loading Chart for MXCT ...